(WSJ) Quantum computing startup Seeqc Inc. has raised more than $11 million in venture capital funding from investors including a subsidiary of German company Merck KGaA, which is interested in using the technology for materials science and pharmaceutical development.
M Ventures, the corporate venture arm of Merck, has invested $5 million in Elmsford, N.Y.-based Seeqc, betting that in several years, the startup’s technology could save Merck time and money related to simulating drugs and chemicals. The Series A is expected to close later this spring, according to a Seeqc spokesperson.
“We think this technology will change the world of simulations for us if it proves to be scalable,” said Philipp Harbach, head of in silico research at Merck.

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

0